GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis AS (OTCPK:NVZMY) » Definitions » EBITDA Margin %

Novonesis AS (Novonesis AS) EBITDA Margin % : 22.66% (As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Novonesis AS EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Novonesis AS's EBITDA for the three months ended in Dec. 2023 was $153 Mil. Novonesis AS's Revenue for the three months ended in Dec. 2023 was $673 Mil. Therefore, Novonesis AS's EBITDA margin for the quarter that ended in Dec. 2023 was 22.66%.


Novonesis AS EBITDA Margin % Historical Data

The historical data trend for Novonesis AS's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis AS EBITDA Margin % Chart

Novonesis AS Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.25 34.61 36.12 34.84 30.57

Novonesis AS Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.64 25.96 19.82 26.57 22.66

Competitive Comparison of Novonesis AS's EBITDA Margin %

For the Specialty Chemicals subindustry, Novonesis AS's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novonesis AS's EBITDA Margin % Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Novonesis AS's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Novonesis AS's EBITDA Margin % falls into.



Novonesis AS EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Novonesis AS's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=800.462/2618.804
=30.57 %

Novonesis AS's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=152.601/673.465
=22.66 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novonesis AS  (OTCPK:NVZMY) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Novonesis AS EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Novonesis AS's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Novonesis AS (Novonesis AS) Business Description

Address
Krogshoejvej 36, Bagsvaerd, DNK, 2880
Novozymes is the world leader in industrial enzymes. In recent years, the company has expanded into micro-organisms, primarily for agricultural markets. The firm supplies five major industry groups: household care, food and beverages, bioenergy, agriculture and feed, and technical and pharma. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark.

Novonesis AS (Novonesis AS) Headlines

From GuruFocus

2 Holdings to Reduce Based on Analyst Recommendations

By Alberto Abaterusso Alberto Abaterusso 11-06-2019

Not Just Yogurt Anymore

By PRNewswire 10-26-2023

Novozymes A/S's Dividend Analysis

By GuruFocus Research 10-19-2023